Short Guide on Patient Partnerships in Rare Disease Research Projects – Basic, Pre-clinical, Translational & Social

1:1
This practical “Short Guide on Patient Partnerships in Rare Disease Research Projects” was created by the European Joint Programme on Rare Diseases (EJP RD) to show scientists, funders and patient organisations how to build meaningful, two-way collaborations in basic, pre-clinical, translational and social-science studies.

It explains why early and sustained patient involvement boosts relevance, impact and funding success, and provides concrete examples, check-lists and real-life testimonials to help consortia avoid common pitfalls and design truly patient-centred projects.

Key publication details

• Full title: Short Guide on Patient Partnerships in Rare Disease Research Projects – Basic, Pre-clinical, Translational & Social
• Authors: Working Group “Patient Engagement in Biomedical Research Projects” (PENREP), chaired by EURORDIS and convened under the European Joint Programme on Rare Diseases (EJP RD).
• Scientific reviewers: Prof. Hanns Lochmüller (CHEO Research Institute, Canada) and Prof. Danny Huylebroeck (KU Leuven, Belgium).
• First publication date: July 2020
• Publisher/Imprint: European Joint Programme on Rare Diseases (EJP RD), Paris (FR).

publication

Year of publication

2020

Author

Working Group “Patient Engagement in Biomedical Research Projects” (PENREP), chaired by EURORDIS and convened under the European Joint Programme on Rare Diseases (EJP RD).

You might also be interested in

June 7 - June 10
The Open Academy x ERDERA accompanies patient advocates by offering rare-disease specific comprehensive training programmes that empower advocates with the knowledge, skills and confidence they need to engage with different stakeholders as equal partners.
ERDERA’s ethics and regulatory experts are launching a dedicated webinar series to help the rare disease research community navigate two fast-moving areas of biomedical research: Advanced Therapy Medicinal Products (ATMPs) and Artificial Intelligence.
The 2026 Open Academy x ERDERA Schools in Barcelona brought patient advocates and early-career researchers together for practical training on medicines development, translational research and meaningful participation in rare disease research.
From 25–28 May in Barcelona, the EURORDIS-led Open Academy x ERDERA Schools will bring patient advocates and early-career researchers together for four days of rare disease training, exchange and peer learning.